Yayınlar & Eserler

Yayın Ağı
Makaleler 60
Tümü (60)
SCI-E, SSCI, AHCI (58)
SCI-E, SSCI, AHCI, ESCI (60)
ESCI (3)
Scopus (60)
TRDizin (7)

1. Dose-Adjusted EPOCH-R in Aggressive B-Cell Lymphomas: Efficacy, Molecular Prognostic Factors, and Real-World Outcomes from a Multicenter Turkish Cohort—A Turkish Oncology Group (TOG) Study

Kidi M. M., Asoglu H., Soysal M., KÖŞECİ T., KARA İ. O., ŞAHİN B., et al.
Medicina (Lithuania) , cilt.62, sa.6, 2026 (SCI-Expanded, Scopus)

2. Expression and prognostic value of cytotoxic T-lymphocyte-associated 4 protein in classic Hodgkin lymphoma

Sahin T. K., Gungor H. N., Gezmis E., Sahin E. A., BARIŞTA İ., AYHAN E. A., et al.
Expert Review of Hematology , 2026 (SCI-Expanded, Scopus)

3. Fear of Cancer Recurrence and Associated Factors in Lymphoma Survivors and Their Family Caregivers: A Cross-Sectional Study

ŞAHİN T. K., Sahin E. A., Gungor H. N., GÜVEN D. C., BARIŞTA İ., AKIN S.
CANCER MEDICINE , cilt.14, sa.7, 2025 (SCI-Expanded, Scopus)

4. Serum Albumin-Creatinine Ratio and Anthracycline Cardiotoxicity in Patients with Cancer

BAŞ O., Guduk N., Tokatli M., Guven D. C., ÖZER N., ŞENER Y. Z., et al.
JOURNAL OF CLINICAL MEDICINE , cilt.14, sa.5, 2025 (SCI-Expanded, Scopus)

5. Immunohistochemical expression of p53 in adult Burkitt lymphomas

Ozogul E., Sayinalp B., Uner A., Ayhan A. S., Akin S., Barista I., et al.
VIRCHOWS ARCHIV , 2024 (SCI-Expanded, Scopus)

6. Fear of cancer recurrence and its predictors in lymphoma patients and their family caregivers: A cross-sectional study

Sahin T. K., Sahin E. A., Gungor H. N., Guven D. C., Barista I., Akin S.
ANNALS OF ONCOLOGY , 2024 (SCI-Expanded, Scopus)

7. Comprehensive analysis of orbital lymphoma in a Turkish cohort: clinical characteristics, histological subtypes, treatment modalities, prognostic factors, and implications for management

AKYILDIZ A., Ismayilov R., Rustamova N., Tokatli M., KOÇ İ., AKIN S., et al.
Annals of Hematology , cilt.103, sa.3, ss.905-915, 2024 (SCI-Expanded, Scopus)

8. Bilateral Testicular Plasmacytoma Preceding Multiple Myeloma with Extramedullary Renal Involvement: A Case Report

KAVGACI G., KÖKSAL B., ARIK Z., BARIŞTA İ., AKIN S.
PLASMATOLOGY , cilt.18, 2024 (ESCI, Scopus)

9. Treatment options in primary mediastinal B cell lymphoma patients, retrospective multicentric analysis; a Turkish oncology group study

Acar R., PAYDAŞ S., Yildirim M., Kiliçarslan E., Sahin U., DOĞAN A., et al.
Journal of Cancer Research and Therapeutics , cilt.19, sa.8, 2023 (SCI-Expanded, Scopus)

10. Biochemical Response Evaluation on Lymphomas: Proposing a Scoring System

ERDAT E. C., ARIK Z., BARIŞTA İ.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.33, sa.3, ss.170-178, 2023 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

11. Bilateral primary breast lymphoma in a pregnant woman: a case report and literature review

YILDIRIM H. Ç., AKYILDIZ A., Ismayilov R., Demirok N., BENLİ B. S., Guven D. C., et al.
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY , cilt.15, sa.4, ss.307-310, 2022 (ESCI, Scopus)

12. A Rare Central Nervous System Involvement Due to CTLA-4 Gene Defect

Rovshanov S., GÖÇMEN R., BARIŞTA İ., ÇAĞDAŞ AYVAZ D. N., ÜNER A., Çilingir V., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , cilt.59, sa.3, ss.248-252, 2022 (SCI-Expanded, Scopus, TRDizin)

13. Sarcopenia and anthracycline cardiotoxicity in patients with cancer

BAŞ O., ERDEMİR A. G., ONUR M. R., ÖZER N., ŞENER Y. Z., AKSU S., et al.
BMJ SUPPORTIVE & PALLIATIVE CARE , 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. Easier and more explanatory indices by integrating leukocyte lymphocyte ratio (LLR) and prognostic nutritional index (PNI) to IPS systems in cases with classical Hodgkin lymphoma

PAYDAŞ S., LAÇİN Ş., Dogan M., BARIŞTA İ., Yildiz B., SEYDAOĞLU G., et al.
LEUKEMIA RESEARCH , cilt.107, 2021 (SCI-Expanded, Scopus)

15. Effectiveness of bendamustine in relapsed or refractory lymphoma cases: a Turkish Oncology Group study

Karadurmus N., PAYDAŞ S., Esin E., Surmeli Z. G., Yildiz B., Erturk I., et al.
ARCHIVES OF MEDICAL SCIENCE , cilt.17, sa.4, ss.920-927, 2021 (SCI-Expanded, Scopus) Creative Commons License

16. IPS-3 Validation in 1012 cases with classical hodgkin lymphoma

PAYDAŞ S., LAÇİN Ş., Dogan M., BARIŞTA İ., Yildiz B., SEYDAOĞLU G., et al.
LEUKEMIA RESEARCH , cilt.102, 2021 (SCI-Expanded, Scopus)

17. Central nervous system involvement in patients with acute myeloid leukemia

YAŞAR H. A., ÇINAR O. E., Koylu N. Y., BARIŞTA İ., GÖKER H., BÜYÜKAŞIK Y.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.5, ss.2351-2356, 2021 (SCI-Expanded, Scopus, TRDizin)

18. Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience

Bekoz H., ÖZBALAK M. M., Karadurmus N., PAYDAŞ S., Turker A., TOPTAŞ T., et al.
ANNALS OF HEMATOLOGY , cilt.99, sa.11, ss.2565-2576, 2020 (SCI-Expanded, Scopus)

19. Demographical and Clinical Features of Marginal Zone Lymphomas: A Retrospective Study of Turkish Oncology Group (TOG)

Turkkan G., Alkan A., PAYDAŞ S., TANRIVERDİ Ö., Karakas Y., Karadurmus N., et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , cilt.36, sa.4, ss.640-645, 2020 (SCI-Expanded, Scopus) Creative Commons License

20. Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort Study

OKAY M., Aslan T., Ozdemir E., ÜNER A., Saglam A., Gungor E., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.2, ss.84-90, 2020 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma

21. Recombinant Zoster Vaccine Significantly Reduces the Impact on Quality of Life Caused by Herpes Zoster in Adult Autologous Hematopoietic Stem Cell Transplant Recipients: A Randomized Placebo-Controlled Trial (ZOE-HSCT)

Curran D., Matthews S., Rowley S. D., Young J. H., Bastidas A., Anagnostopoulos A., et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION , cilt.25, sa.12, ss.2474-2481, 2019 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

22. Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation A Randomized Clinical Trial

Bastidas A., de la Serna J., El Idrissi M., Oostvogels L., Quittet P., Lopez-Jimenez J., et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION , cilt.322, sa.2, ss.123-133, 2019 (SCI-Expanded, Scopus) Creative Commons License

23. Anthracyclin - Based Chemotherapy in Patients with Non-Hodgkin Lymphoma Aged Over 75

Sarici F., KERTMEN N., Aslan A. C., Tasdemir V., BABACAN T., KILIÇKAP S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.2, ss.89-95, 2016 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma

24. AGGRESSIVE FIBROMATOSIS IN CHILDREN: A SINGLE CENTER EXPERIENCE

Varan A., Akyuz C., AYDIN G. B., Yildiz F., Barista I., Yalcin B., et al.
PEDIATRIC BLOOD & CANCER , cilt.61, 2014 (SCI-Expanded, Scopus)

25. Clinical Features and Prognostic Factors of Hodgkin's Lymphoma: A Single Center Experience

KILIÇKAP S., BARIŞTA İ., ÜLGER Ş., ÇELİK İ., SELEK U., YILDIZ F., et al.
BALKAN MEDICAL JOURNAL , cilt.30, sa.2, ss.178-185, 2013 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma

26. Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab

AKYÜREK N., ÜNER A., BENEKLİ M., BARIŞTA İ.
CANCER , cilt.118, sa.17, ss.4173-4183, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

27. Long-term complications in Hodgkin's lymphoma survivors

KILIÇKAP S., BARIŞTA İ., Ulger S., ÇELİK İ., SELEK U., Gullu I., et al.
TUMORI , cilt.98, sa.5, ss.601-606, 2012 (SCI-Expanded, Scopus)

28. Rapid-Infusion Rituximab in Lymphoma Treatment: 2-Year Experience in a Single Institution

Atay S., BARIŞTA İ., GÜNDOĞDU F., Akgedik K., Arpaci A.
JOURNAL OF ONCOLOGY PRACTICE , cilt.8, sa.3, ss.141-143, 2012 (SCI-Expanded, ESCI, Scopus) Creative Commons License

29. The presence of Epstein-Barr virus (EBV) in diffuse large B-cell lymphomas (DLBCLs) in Turkey: special emphasis on 'EBV-positive DLBCL of the elderly'

ÜNER A., AKYÜREK N., Saglam A., Abdullazade S., Uzum N., Onder S., et al.
APMIS , cilt.119, ss.309-316, 2011 (SCI-Expanded, Scopus)

30. Symmetrical primary cutaneous marginal zone lymphoma associated with rheumatoid arthritis

YILDIRIM F., KARADUMAN A., HÜRMÜZ P., Ozyar E., BARIŞTA İ., Saglam A.
JOURNAL OF CUTANEOUS PATHOLOGY , cilt.37, sa.5, ss.600-604, 2010 (SCI-Expanded, Scopus)

31. Fitting the Pieces of the POEMS Syndrome Jigsaw Puzzle-Guillain-Barre Syndrome in a Patient with Refractory Ascites: Case Report

Shorbagi A., ÖNAL İ. K., Onal E. D., KILIÇKAP S., BARIŞTA İ., Kansu T., et al.
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , cilt.30, sa.1, ss.352-355, 2010 (SCI-Expanded, Scopus) Creative Commons License

32. Oxaliplatin Induced Hemolytic Anemia

Harputluoglu H., Dizdar O., AKSOY S., BARIŞTA İ.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.19, sa.2, ss.127-128, 2009 (SCI-Expanded, Scopus, TRDizin)

33. Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma

KILIÇKAP S., Yavuz B., AKSOY S., Sahiner L., DİNÇER M., HARPUTLUOĞLU H., et al.
MEDICAL ONCOLOGY , cilt.25, sa.4, ss.437-442, 2008 (SCI-Expanded, Scopus)

34. Liver dysfunction after chemotherapy in lymphoma patients infected with hepatitis C

DİZDAR Ö., Tapan U., AKSOY S., Harputluoglu H., KILIÇKAP S., BARIŞTA İ.
EUROPEAN JOURNAL OF HAEMATOLOGY , cilt.80, sa.5, ss.381-385, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

35. Prognostic impact of bone turnover markers in multiple myeloma

Dizdar O., Barista I., Kalyoncu U., Karadag O., Celik I., Kars A., et al.
JOURNAL OF CLINICAL ONCOLOGY , cilt.26, sa.15, 2008 (SCI-Expanded, Scopus)

36. Characteristics of breast cancer patients with central nervous system metastases: A single-center experience

Harputluoglu H., DİZDAR Ö., AKSOY S., KILIÇKAP S., Dede D. S., Ozisik Y., et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.100, sa.5, ss.521-526, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

37. Clinicopathologic evaluation of non-Hodgkin lymphoma (NHL): A single centre experience

Kilickap S., Barista I., Turkmen E., Dizdar O., Aksoy S., Turker A., et al.
JOURNAL OF CLINICAL ONCOLOGY , cilt.26, sa.15, 2008 (SCI-Expanded, Scopus)

38. Rituximab-induced viral infections in lymphoma patients

Aksoy S., Harputluoglu H., Kilickap S., Dede D. S., Dizdar O., Altundag K., et al.
JOURNAL OF CLINICAL ONCOLOGY , cilt.25, sa.18, 2007 (SCI-Expanded, Scopus)

39. Early and late arrhythmogenic effects of doxorubicin

Kilickap S., Barista I., Akgul E., Aytemir K., Aksoy S., Tekuzman G.
SOUTHERN MEDICAL JOURNAL , cilt.100, sa.3, ss.262-265, 2007 (SCI-Expanded, Scopus)

40. Rituximab-related viral infections in lymphoma patients

Aksoy S., Harputluoglu H., Kilickap S., Dede D. S., Dizdar O., Altundag K., et al.
LEUKEMIA & LYMPHOMA , cilt.48, sa.7, ss.1307-1312, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

41. Macrophage inflammatory protein-1 alpha: A link between innate immunity and familial mediterranean fever?

Dizdar O., Kalyoncu U., Karadag O., Akdogan A., Kiraz S., Ertenli I., et al.
CYTOKINE , cilt.37, sa.1, ss.92-95, 2007 (SCI-Expanded, Scopus)

42. Successful treatment of myelodysplastic syndrome-induced pyoderma gangrenosum

Koca E., Duman A. E., Cetiner D., Buyukasik Y., Haznedaroglu I. C., ÜNER A., et al.
NETHERLANDS JOURNAL OF MEDICINE , cilt.64, sa.11, ss.422-424, 2006 (SCI-Expanded, Scopus)

43. Reply to "Troponins in prediction of cardiotoxic effects", by D. Cardinale et al.

Kilickap S., Barista I., Aytemir K.
ANNALS OF ONCOLOGY , cilt.17, sa.1, 2006 (SCI-Expanded, Scopus)

44. IIVP salvage regimen induces high response rates in patients with relapsed lymphoma before autologous stem cell transplantation

Abali H., Oyan B., Koc Y., Kars A., Barista I., ÜNER A., et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , cilt.28, sa.3, ss.264-269, 2005 (SCI-Expanded, Scopus)

45. Doxorubicin-induced second degree and complete atrioventricular block

Kilickap S., AKGUL E., Aksoy S., Aytemir K., Barista I.
EUROPACE , cilt.7, sa.3, ss.227-230, 2005 (SCI-Expanded, Scopus)

46. Prospective study of combined modality treatment or radiotherapy alone in the management of early-stage adult Hodgkin's disease

Yildiz F., Zengin N., Engin W., Gullu E., Barista I., Caglar M., et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.60, sa.3, ss.839-846, 2004 (SCI-Expanded, Scopus)

47. Lung hilar Ga-67 uptake in patients with lymphoma following chemotherapy

Gunay E., Salanci B., Barista I., Caner B.
ANNALS OF NUCLEAR MEDICINE , cilt.18, sa.5, ss.391-397, 2004 (SCI-Expanded, Scopus)

48. A patient presenting with spinal cord compression who had two distinct follicular cell type thyroid carcinomas

Koca E., Sokmensuer C., Yildiz B., Engin H., Bozkurt M., Aras T., et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , cilt.27, sa.6, ss.562-564, 2004 (SCI-Expanded, Scopus)

49. Comments on "Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma" by M. Binn, A. Ruskone-Fourmestraux, E. Lepage et al. (Ann Oncol 2003; 14 : 1751-1757)

Abali H., Barista I.
ANNALS OF ONCOLOGY , cilt.15, sa.5, ss.841-842, 2004 (SCI-Expanded, Scopus) Creative Commons License

50. Thymic malignancy in a breast cancer patient - Is there an association with anti-estrogenic effects of tamoxifen?

Oyan B., Aksoy S., Yavas O., Kars A., Turker A., Barista I.
ACTA ONCOLOGICA , cilt.43, sa.1, ss.115-116, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

51. Prognostic factors and outcome in 306 patients with diffuse large B-cell lymphoma (DLBCL)

OYAN ULUÇ B., Tekuzman G., BARIŞTA İ., Ozisik Y., kars A., Turker A., et al.
ANNALS OF ONCOLOGY , cilt.15, ss.153, 2004 (SCI-Expanded, Scopus)

52. Biweekly irinotecan plus bolus 5-fluorouracil and folinic acid in patients with advanced stage colorectal cancer

Yalcin S., Oksuzoglu B., Tekuzman G., Engin H., Celik I., Turker A., et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY , cilt.33, sa.11, ss.580-583, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

53. Weekly irinotecan in patients with metastatic colorectal cancer failing 5-fluorouracil-based chemotherapy: Efficacy and prognostic factors

Karaoglu A., Yalcin S., Tekuzman G., Kars A., Celik I., Guler N., et al.
TUMORI , cilt.89, sa.2, ss.141-145, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

54. Modified ESHAP as salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma: Results of a single-center study of 32 patients

Ozturk M., Barista I., Altundag M., Turker A., Yalcin S., Celik I., et al.
CHEMOTHERAPY , cilt.48, sa.5, ss.252-258, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

55. An unusual case of metastatic rectal carcinoma presenting as thyroid nodule

Koklu S., Barista I., Altundag M., Aksu S., Firat P.
AMERICAN JOURNAL OF GASTROENTEROLOGY , cilt.95, sa.12, ss.3689, 2000 (SCI-Expanded, Scopus)

56. Gastric lymphomas in Turkey - Analysis of prognostic factors with special emphasis on flow cytometric DNA content

Aydin Z., Barista I., Canpinar H., Sungur A., Tekuzman G.
CANCER , cilt.89, sa.1, ss.12-20, 2000 (SCI-Expanded, Scopus)

57. Intrathecal cytarabine and bone marrow suppression

Barista I.
JOURNAL OF CLINICAL ONCOLOGY , cilt.18, sa.9, ss.2003, 2000 (SCI-Expanded, Scopus)

58. Interferon alfa-2b, colchicine, and benzathine penicillin versus colchicine and benzathine penicillin in Behcet's disease: a randomised trial

Demiroglu H., Ozcebe O., Barista I., Dundar S., Eldem B.
LANCET , cilt.355, sa.9204, ss.605-609, 2000 (SCI-Expanded, Scopus)

59. Primary breast lymphomas - A retrospective analysis of twelve cases

Barista I., Baltali E., Tekuzman G., Kars A., Ruacan S., Ozisik Y., et al.
ACTA ONCOLOGICA , cilt.39, sa.2, ss.135-139, 2000 (SCI-Expanded, Scopus)

60. Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy

Barista I., Tekuzman G., Yalcin S., Gullu I., Guler N., Ozisik Y., et al.
JOURNAL OF SURGICAL ONCOLOGY , cilt.73, sa.1, ss.12-16, 2000 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 17

1. Relationship between sarcopenia and anthracycline related cardiotoxicity in patients with cancer

Bas O., Erdemir A., Onur R., Guner G., Guven D. C., Aksu S., et al.
ESMO Virtual Congress, ELECTR NETWORK, 19 Eylül - 18 Ekim 2020, cilt.31, (Özet Bildiri) Creative Commons License Sürdürülebilir Kalkınma

2. İki olgu nedeniyle Nivolimumaba bağlı akciğer toksisitesi

BABAOĞLU E., SARINÇ ULAŞLI S., KÖKSAL D., ERMAN M., BARIŞTA İ.
Ulusal Akciğer Sağlığı Kongresi, Türkiye, 14 - 18 Mart 2018, (Özet Bildiri)

3. NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: EXPERIENCE IN TURKEY

Ferhanoglu B., Bekoz H., Karadurmus N., Paydas S., Gulbas Z., Turker A., et al.
22nd Congress of the European-Hematology-Association, Madrid, İspanya, 22 - 25 Haziran 2017, cilt.102, ss.84-85, (Özet Bildiri)

4. Effectiveness of bendamustine in relapse or refractory lymphoma cases: A report from Turkey-The Turkish Oncology Group (TOG) study.

Karadurmus N., Paydas S., Ocal R., Yildiz B., Nayir E., Dogan M., et al.
53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 2 - 07 Haziran 2017, cilt.35, (Özet Bildiri)

5. Single Agent Gemcitabine As a Salvage Regimen in Patients with Relapsed/Refractory Hodgkin's Lymphoma after Autologous Stem Cell Transplantation

ÖZDEMİR E., Aslan A., Turker A., BARIŞTA İ., Kars A.
57th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 5 - 08 Aralık 2015, cilt.126, (Özet Bildiri)

6. Gemcitabine in Combination with Oxaliplatin (GEMOX) As a Salvage Regimen in Patients with Relapsed/Refractory Hodgkin's Lymphoma

ÖZDEMİR E., Aslan A., Turker A., BARIŞTA İ., Kars A.
57th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 5 - 08 Aralık 2015, cilt.126, (Özet Bildiri)

7. The retrospective analysis of central nervous system lymphomas: Single-center experience.

Sunar V., Yasar A., Sarici F., Esin E., Diker O., Lacin S., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)

8. Autologous/Allogeneic Stem Cell Transplantation following High-dose Sequential Chemotherapy in Patients with Stage III-IV Burkitt and Lymphoblastic Lymphoma : Long term survival data from LLBL2001 protocol

Gungor B., Unsal C., Barista I., Adam M., Koc Y.
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, (Özet Bildiri)

9. HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BLOOD STEM CELL TRANSPLANTATION IN REFRACTORY/METASTATIC NON-SEMINOMATOUS GERM CELL TUMORS: GATA SINGLE CENTER RESULTS

Karadurmus N., Ataergin A. S., Erdem G., Cakar M., Barista I., Turker T., et al.
37th Congress of the European-Society-for-Medical-Oncology (ESMO), Vienna, Avusturya, 28 Eylül - 02 Ekim 2012, cilt.23, ss.286, (Özet Bildiri)

10. The comparison of up-front autologous peripheral stem cell transplantation in first remission and long-lasting intensive chemotherapy protocols in highly aggressive non-Hodgkin's lymphomas: Results of a retrospective analysis.

Ozturk M., Ozaydin S., Oyan B., ÖZBALAK M. M., Arpaci F., Paydas S., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri)

11. BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphomas (DLBCL)

Akyurek N., ÜNER A., Benekli M., Barista I.
99th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Washington, Kiribati, 20 - 26 Mart 2010, cilt.90, (Özet Bildiri)

12. Characteristics of breast cancer patients with central nervous system metastases and factors associated with survival after development of central nervous system metastasis

Harputluoglu H., Dizdar O., Aksoy S., Kilickap S., Dede D. S., Ozisik Y., et al.
30th Annual San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 13 - 16 Aralık 2007, cilt.106, (Özet Bildiri) Sürdürülebilir Kalkınma

13. Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma

Kilickap S., Yavuz B., Aksoy S., Sahiner L., Harputluoglu H., Dincer M., et al.
30th Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.202, (Özet Bildiri)

14. Biochemical markers of bone turnover in the diagnosis of myeloma bone disease.

Dizdar O., Barista I., Kalyoncu U., Karadag O., Celik I., Kars A., et al.
41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 13 - 17 Mayıs 2005, cilt.23, (Özet Bildiri)

15. Increased Troponin-T level is associated with anthracycline-induced diastolic dysfunction of the left ventricle.

Kilickap S., Barista I., Akgul E., Aytemir K., Aksoyek S., Celik I., et al.
40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Haziran 2004, cilt.22, (Özet Bildiri)

16. Clinicopathological features and outcome of primary gastric lymphoma: A series of 73 cases

Oyan B., Tekuzman G., Barista I., Kars A., Turker A., Ozisik Y., et al.
40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Haziran 2004, cilt.22, (Özet Bildiri)

17. PTEN expression in diffuse large B-cell lymphomas

Onder S., Barista I., Sungur A., Ruacan S., ÜNER A.
17th European and African Division Meeting of the International-Society-of-Haematology, Graz, Avusturya, 7 - 10 Eylül 2003, ss.125-131, (Tam Metin Bildiri)
Metrikler

Yayın

77

Yayın (WoS)

76

Yayın (Scopus)

60

Atıf (WoS)

660

H-İndeks (WoS)

13

Atıf (Scopus)

603

H-İndeks (Scopus)

10

Atıf (Scholar)

4

H-İndeks (Scholar)

1

Proje

4

Tez Danışmanlığı

3

Açık Erişim

15
BM Sürdürülebilir Kalkınma Amaçları
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER
SDG 16: AMAÇ 16: BARIŞ VE ADALET